Sponsor pipeline

Avalyn Pharma Inc. clinical trial pipeline

3 active trials 2 recruiting 3 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-11

Trial sites expanded: 3 → 24 locations

NCT07194382 AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02… · Phase 2

2026-08-08

Trial sites expanded: 54 → 68 locations

NCT06951217 An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) · Phase 2

Phase 2

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT07194382	AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02…	Idiopathic Pulmonary Fibrosis (IPF)	Recruiting	2026-08-10
NCT06951217	An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)	Progressive Pulmonary Fibrosis	Recruiting	2026-08-07
NCT06329401	A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With…	Pulmonary Fibrosis	Active, Not Recruiting	2026-07-02

Get alerts when Avalyn Pharma Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.